Evaluating the bone-regenerative role of the decellularized porcine bone xenograft in a canine extraction socket model.

Within the limits of the study, we concluded that ABCcolla® treated defects demonstrated significantly more new bone formation and better bone bridging, but less amount of fluorescent labeling than those of the Bio-Oss® group. However, clinical studies in humans are recommended to confirm these findings.